Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Alternative donor

12 Mar 2020

Abstract excerpt

Sickle cell disease (SCD) is an inherited disorder; despite significant improvements in supportive care, SCD continues to cause substantial morbidity, mortality, and reduced life expectancy. Allogeneic hematopoietic stem cell transplantation (HSCT) is currently the only widely available curative therapy for SCD, which is offered as a standard of care for patients with a matched sibling donor (MSD). Donor...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Hemoglobinopathies and Related Disorders
Share to Parvovirus B19 Infection Studies
Share to Prenatal Screening and Diagnostics

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 32202248
DOI: 10.1016/j.hemonc.2019.12.006

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Alternative donorPMID 32202248Read ↗

Stem cell transplantation in sickle cell disease: therapeutic potential and challenges facedSemantic proximity Read ↗

Update of hematopoietic cell transplantation for sickle cell diseaseSemantic proximity Read ↗

Outcomes and long-term effects of hematopoietic stem cell transplant in sickle cell diseaseSemantic proximity Read ↗

Allogeneic haemopoietic stem cell transplantation in children: what alternative donor should we choose when no matched sibling is available?Semantic proximity Read ↗

Curative approaches for sickle cell disease: A review of allogeneic and autologous strategiesSemantic proximity Read ↗

Hematopoietic stem cell transplants from unrelated donorsSemantic proximity Read ↗

Ethical Challenges in Hematopoietic Cell Transplantation for Sickle Cell DiseaseSemantic proximity Read ↗

Haplo‐identical or mismatched unrelated donor hematopoietic cell transplantation for Fanconi anemia: Results from the Severe Aplastic Anemia Working Party of the EBMTSemantic proximity Read ↗

Allogeneic hematopoietic stem cell transplantation for sickle cell disease: the time is nowSemantic proximity Read ↗

Children as Hematopoietic Stem Cell DonorsSemantic proximity Read ↗

Haploidentical hematopoietic stem cell transplantation in children and adolescents with acquired severe aplastic anemiaSemantic proximity Read ↗

Matched Family versus Alternative Donor Hematopoietic Stem Cell Transplantation for Patients with Thalassemia Major: Experience from a Tertiary Referral Center in South IndiaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.